April 13, 2026
As demand grows for rapid, non-invasive, and comprehensive biomarker testing in oncology, liquid biopsies have become a powerful tool for tumor mutation profiling—supporting patient care and serving as an alternative when tissue samples are insufficient, lesions are inaccessible, or timely decisions are needed.
